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The electrocardiogram (ECG) serves as the gold standard of heart rate (HR) monitoring but is 
rarely used outside of a clinical environment. Newly developed wearable technology is more 
usable outside of a clinical setting, but has not been validated against this gold standard. 
Increased ease of use as well as increased portability will allow for more flexible study 
design. PURPOSE: The purpose of this study is to determine the validity of a wrist mounted 
photoplethysmography (PPM) device used for measuring HR during incremental treadmill 
exercise using ECG as the criterion HR measurement. METHODS: Twenty-two subjects (13 
men, 9 women; 35.8 ± 6.3 yr, 14.6 ± 7.5 % body fat, VO2max: 55.5 ± 0.49 ml·kg-1·min-1) 
performed a Bruce treadmill protocol graded exercise test. HR was recorded at rest and at the 
end of each minute with the Mio Alpha PPM device and ECG simultaneously. HR was compared 
between methods across the entire testing session (rest and exercise values) and separately for 
each exercise test stage using paired-samples t-tests. Validity coefficients were determined 
using the Pearson correlation. RESULTS: HR across the entire intensity range (rest to maximal 
exercise) exhibited a significant correlation between methods (r = 0.97, p < 0.001). However, 
HR was significantly different (overall mean HR: ECG = 124 ± 39 b·min-1, Mio = 123 ± 37 
b·min-1, t359 = -2.504, p = 0.013). Significant correlations were observed at rest and each exercise 
test stage, with r values ranging from 0.67 to 0.96 (all p < 0.001). HR was significantly different 
between methods at rest (ECG = 66 ± 13 b·min-1, Mio = 68 ± 16 b·min-1), stage 3 (ECG = 144 ± 
13 b·min-1, Mio = 143 ± 13 b·min-1, p = 0.014), stage 4 (ECG = 168 ± 13 b·min-1, Mio = 164 ± 14 
b·min-1, p = 0.004), and stage 5 (ECG = 178 ± 12 b·min-1, Mio = 173 ± 18 b·min-1, p = 
0.039). CONCLUSION: Correlational analyses indicated a strong agreement between HR 
methods overall, as well as individually at rest and during each exercise test stage. However, 
mean comparisons observed significant differences between methods. From a practical 
standpoint, the mean difference between methods did not exceed 3 b·min-1 except for stage 5. 
Therefore, a PPM device may not provide accurate HR monitoring at maximal exercise 
intensities.  
